Simplify Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Simplify Asset Management Inc.
- $1.77 Billion
- Q3 2025
A detailed history of Simplify Asset Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 12,981 shares of REGN stock, worth $7.52 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
12,981
Previous 3,697
251.12%
Holding current value
$7.52 Million
Previous $1.94 Million
276.19%
% of portfolio
0.41%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,433Shares Held
88.8MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.46 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.28 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.8 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.22 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...